Skip to main content
. 2017 Feb 1;13(2):171–177. doi: 10.1007/s11420-016-9537-1

Fig. 1.

Fig. 1

a A peak response in bone marker NTx was observed at 4–8 months in both non-responders and responders while the peak response in BSAP was observed at 8–12 months in non-responders and at 4–8 months in responders. b The magnitude of BSAP was significantly higher in the non-responders compared to TPTD responders only at 4 months (p = 0.04).